Product
Sodium Thiosulfate
Aliases
Sodium Thiosulphate
6 clinical trials
16 indications
Indication
Kidney TransplantIndication
hepatoblastomaIndication
DermatomyositisIndication
Idiopathic Inflammatory MyopathiesIndication
Brain TumorIndication
Central Nervous System TumorIndication
Childhood Germ Cell TumorIndication
Germ Cell TumorIndication
Liver CancerIndication
NeuroblastomaIndication
OtotoxicityIndication
Ovarian CancerIndication
SarcomaIndication
Stomach AdenocarcinomaIndication
Esophagogastric junctionIndication
Stomach CancerClinical trial
Evaluation of Thiosulfate Enhanced Organ Preservation Solution in Kidney TransplantationStatus: Not yet recruiting, Estimated PCD: 2026-03-01
Clinical trial
A Phase 3 Multi-institutional Study for Treatment of Children With Newly Diagnosed Hepatoblastoma Using a Modified PHITT Strategy Incorporating a Randomized Assessment of Sodium Thiosulfate as Otoprotection for Children With Localized Disease, and Response Adapted Therapy for Patients With Metastatic DiseaseStatus: Recruiting, Estimated PCD: 2026-03-31
Clinical trial
An Open-label Study of Sodium Thiosulfate for Treatment of Calcinosis Associated With Juvenile and Adult DermatomyositisStatus: Completed, Estimated PCD: 2022-11-04
Clinical trial
A Randomized Phase III Study of Sodium Thiosulfate for the Prevention of Cisplatin-Induced Ototoxicity in ChildrenStatus: Completed, Estimated PCD: 2015-04-09
Clinical trial
A Phase II Study of Sodium Thiosulfate (STS) for Prevention of Ototoxicity in Patients With Locally Advanced Squamous Cell Carcinoma of Head and Neck (SCCHN) Undergoing Concurrent Chemoradiation With CisplatinStatus: Completed, Estimated PCD: 2023-05-31
Clinical trial
Phase II Trial of Heated Intraperitoneal Chemotherapy and Gastrectomy for Gastric Cancer With Positive Peritoneal CytologyStatus: Active (not recruiting), Estimated PCD: 2025-10-01